BACKGROUND: Benign intracranial @entity101 is due to an @entity428 of unknown cause. The initial symptoms, complications and associations with medical conditions are discussed. CASE REPORT: A 6-year-old @entity1 developed symptoms of benign intracranial @entity101 following reduction of oral corticosteroid therapy. Laboratory studies and head-computed tomographic scan were normal. Examination of the optic discs showed bilateral @entity1829 and the cerebrospinal fluid pressure was increased. The @entity1 was given prednisone therapy 1 mg/kg daily initially, associated with @entity3791 , and removal of 25 mL of cerebrospinal fluid. All the symptoms resolved and the treatment was gradually decreased. The @entity1 developed no further @entity227 . CONCLUSION: Benign intracranial @entity101 with the risk of permanent @entity227 is a complication underrecognized in @entity1 . All @entity1 receiving large doses of the @entity288 who complain of @entity227 , particularly following a reduction of @entity228 dosage, should have an ophtalmoscopic examination to exclude this complication.

[Benign intracranial XXXX : an unrecognized complication of corticosteroid therapy].

@entity1 :: ('9606', 'Species') :: ['children', 'girl', 'patients', 'patient', 'child'] @entity227 :: ('MESH:D014786', 'Disease') :: ['visual loss', 'headache or blurring vision', 'visual failure'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity428 :: ('MESH:D019586', 'Disease') :: ['increased intracranial pressure'] @entity3791 :: ('MESH:D000086', 'Chemical') :: ['acetazolamide'] @entity228 :: ('CHEBI:50858', 'Chemical') :: ['corticosteroid'] @entity1829 :: ('MESH:D010211', 'Disease') :: ['papilledema'] @entity288 :: ('MESH:D000305', 'Chemical') :: ['corticosteroids']
@entity101 :: (MESH:D006973,Disease) :: ['hypertension']
